Joseph Cuschieri1. 1. Department of Surgery, University of Cincinnati, Ohio USA.
Abstract
BACKGROUND: Lipid rafts are membrane microdomains characterized by an enriched cholesterol environment and appear to serve as a platform for signaling. Their role within the macrophage during endotoxin exposure is unknown. METHODS: THP-1 cells were subjected to lipopolysaccharide stimulation with or without methyl-beta-cyclodextrin (MbetaCD) pretreatment, a cholesterol depleting agent. Cell surface expression of toll-like receptor-4 (TLR4) and platelet-activating factor receptor (PAFr) was determined by flow cytometry. Membrane receptor components and activation of the mitogen-activated protein kinases (MAPK) was determined from lipid raft and cellular protein by immunoblot. Inflammatory mediator production was determined from harvested supernatants by enzyme-linked immunosorbent assay. RESULTS: Surface expression of TLR4 and PAFr was not affected by MbetaCD. Lipopolysaccharide stimulation led to TLR4 mobilization to lipid rafts, MAPK activation, and inflammatory mediator production. Pretreatment with MbetaCD did not affect TLR4 mobilization to lipid rafts, but did result in lost lipid raft expression of the PAFr coupled G-protein, Galpha1. MbetaCD treatment led to selective attenuation of MAPK activation through ERK 1/2. This dysregulated signaling was associated with attenuated production of tumor necrosis factor-alpha, but increased production of interleukin-10. CONCLUSION: Lipid raft disintegration results in lost expression of Galpha1, dysregulated MAPK signaling, and selective anti-inflammatory mediator production. Therefore, modulation of lipid raft cholesterol content may represent a potential mechanism for regulation of macrophage phenotypic differentiation. Copyright 2004 Elsevier Inc.
BACKGROUND:Lipid rafts are membrane microdomains characterized by an enriched cholesterol environment and appear to serve as a platform for signaling. Their role within the macrophage during endotoxin exposure is unknown. METHODS: THP-1 cells were subjected to lipopolysaccharide stimulation with or without methyl-beta-cyclodextrin (MbetaCD) pretreatment, a cholesterol depleting agent. Cell surface expression of toll-like receptor-4 (TLR4) and platelet-activating factor receptor (PAFr) was determined by flow cytometry. Membrane receptor components and activation of the mitogen-activated protein kinases (MAPK) was determined from lipid raft and cellular protein by immunoblot. Inflammatory mediator production was determined from harvested supernatants by enzyme-linked immunosorbent assay. RESULTS: Surface expression of TLR4 and PAFr was not affected by MbetaCD. Lipopolysaccharide stimulation led to TLR4 mobilization to lipid rafts, MAPK activation, and inflammatory mediator production. Pretreatment with MbetaCD did not affect TLR4 mobilization to lipid rafts, but did result in lost lipid raft expression of the PAFr coupled G-protein, Galpha1. MbetaCD treatment led to selective attenuation of MAPK activation through ERK 1/2. This dysregulated signaling was associated with attenuated production of tumor necrosis factor-alpha, but increased production of interleukin-10. CONCLUSION:Lipid raft disintegration results in lost expression of Galpha1, dysregulated MAPK signaling, and selective anti-inflammatory mediator production. Therefore, modulation of lipid raft cholesterol content may represent a potential mechanism for regulation of macrophage phenotypic differentiation. Copyright 2004 Elsevier Inc.
Authors: Willson Kwok; Sang Ho Lee; Cathy Culberson; Katarzyna Korneszczuk; Mark G Clemens Journal: Am J Physiol Gastrointest Liver Physiol Date: 2009-11 Impact factor: 4.052
Authors: Lesley E Smythies; C Roger White; Akhil Maheshwari; M N Palgunachari; G M Anantharamaiah; Manjula Chaddha; Ashish R Kurundkar; Geeta Datta Journal: Am J Physiol Cell Physiol Date: 2010-03-10 Impact factor: 4.249
Authors: Ingrid R Niesman; Nathan Zemke; Heidi N Fridolfsson; Kristofer J Haushalter; Karen Levy; Anna Grove; Rosalie Schnoor; J Cameron Finley; Piyush M Patel; David M Roth; Brian P Head; Hemal H Patel Journal: Mol Cell Neurosci Date: 2013-07-10 Impact factor: 4.314
Authors: Masaki Uchida; Hisanori Kosuge; Masahiro Terashima; Deborah A Willits; Lars O Liepold; Mark J Young; Michael V McConnell; Trevor Douglas Journal: ACS Nano Date: 2011-03-21 Impact factor: 15.881
Authors: Hongkuan Fan; David L Williams; Basilia Zingarelli; Kevin F Breuel; Giuseppe Teti; George E Tempel; Karsten Spicher; Guylain Boulay; Lutz Birnbaumer; Perry V Halushka; James A Cook Journal: Immunology Date: 2007-05-02 Impact factor: 7.397
Authors: Agnes Fermin Lee; Huan-Yuan Chen; Lei Wan; Sheng-Yang Wu; Jhang-Sian Yu; Annie C Huang; Shi-Chuen Miaw; Daniel K Hsu; Betty A Wu-Hsieh; Fu-Tong Liu Journal: Am J Pathol Date: 2013-08-03 Impact factor: 4.307
Authors: Joshua A Vieth; Moo-kyung Kim; Daniel Glaser; Kaitlyn Stiles; Alan D Schreiber; Randall G Worth Journal: Inflamm Res Date: 2012-09-04 Impact factor: 4.575